Basilea Pharmaceutica AG (BSLN.SW)
Basilea Pharmaceutica AG is a Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
52.30+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-9.8%
The outlook
Basilea Pharmaceutica AG currently reads as leaning bullish based on buy — 2.0 avg of 5 analysts, mixed vs its moving averages, 52% of the way from its 52-week low to high, avg target +66% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 2.0 avg of 5 analysts
Price trendMixed vs its moving averages
52-week range52% of the way from its 52-week low to high
Price targetAvg target +66% vs current price
Analyst price target
~12-month · 5 analysts86.88average target+66.1% vs now
Now 52.30
Low 59.40High 120.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$647.3M
52-wk high
59.20
52-wk low
44.70
50-day avg
51.87
200-day avg
52.45
Trailing P/E
16.7